医药供应链优化整合问题研究
发布时间：2018-11-03 21:55
【摘要】：随着新医改深入推进,药品流通行业迎来新一轮的整合发展。医药供应链面临着国际国内市场竞争加剧、成本高效率低、运营风险增加和药品流通管制制度效率低下等一系列问题。研究表明:医药供应链的优化整合应遵循药品流通的特殊性、平衡经济效益和社会效益、注重与药品流通管制制度相协同等原则。在医药供应链整合的策略上应做好以下五个方面的工作:以药品需求特性为基础对供应链进行分类,通过有效激励促进知识共享与合作,推进信息技术和现代物流技术升级,构建敏捷性供应链支撑药品需求管理以及通过业务流程再造与创建风险管理文化等来规避运营风险。
[Abstract]:With the further development of the new medical reform, the pharmaceutical circulation industry ushered in a new round of integrated development. Pharmaceutical supply chain is faced with a series of problems, such as intensified competition in international and domestic markets, low cost, increased operational risk and low efficiency of drug circulation control system. The research shows that the optimization and integration of pharmaceutical supply chain should follow the particularity of drug circulation, balance economic and social benefits, and pay attention to the coordination with drug circulation control system. In the strategy of pharmaceutical supply chain integration, the following five aspects should be done well: to classify the supply chain based on the characteristics of drug demand, to promote knowledge sharing and cooperation through effective incentives, and to promote the upgrading of information technology and modern logistics technology. To construct agile supply chain to support drug demand management and to avoid operational risk through business process reengineering and risk management culture.
【作者单位】： 中国人民大学商学院;
【分类号】：F426.72;F274
[Abstract]:With the further development of the new medical reform, the pharmaceutical circulation industry ushered in a new round of integrated development. Pharmaceutical supply chain is faced with a series of problems, such as intensified competition in international and domestic markets, low cost, increased operational risk and low efficiency of drug circulation control system. The research shows that the optimization and integration of pharmaceutical supply chain should follow the particularity of drug circulation, balance economic and social benefits, and pay attention to the coordination with drug circulation control system. In the strategy of pharmaceutical supply chain integration, the following five aspects should be done well: to classify the supply chain based on the characteristics of drug demand, to promote knowledge sharing and cooperation through effective incentives, and to promote the upgrading of information technology and modern logistics technology. To construct agile supply chain to support drug demand management and to avoid operational risk through business process reengineering and risk management culture.
【作者单位】： 中国人民大学商学院;
【分类号】：F426.72;F274
【参考文献】
相关期刊论文 前2条
1 周e，
本文编号：2309152
本文链接：https://www.wllwen.com/guanlilunwen/gongyinglianguanli/2309152.html
